Trilink Biotechnologies Since 1996 the company has offered cutting edge services to researchers in the fields of gene therapy, nucleoside chemotherapy, oligonucleotide therapy and diagnostics. We specialize in the manufacture of modified nucleic acid products including custom oligonucleotides, modified nucleoside triphosphates, phosphoramidites and other small molecules. The founders of our company have been on the forefront of the advancements in oligonucleotide synthesis. Our scientists and technicians have decades of collective experience in synthesizing modified nucleosides, nucleotides and oligonucleotides for research, diagnostics and pre-clinical therapeutic applications.